| Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach—the ALBI grade PJ Johnson, S Berhane, C Kagebayashi, S Satomura, M Teng, ... Journal of Clinical Oncology 33 (6), 550, 2015 | 2223 | 2015 |
| Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind … T Meyer, R Fox, YT Ma, PJ Ross, MW James, R Sturgess, C Stubbs, ... The lancet Gastroenterology & hepatology 2 (8), 565-575, 2017 | 442 | 2017 |
| A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer L Kadalayil, R Benini, L Pallan, J O'beirne, L Marelli, D Yu, A Hackshaw, ... Annals of oncology 24 (10), 2565-2570, 2013 | 354 | 2013 |
| Adjuvant capecitabine for biliary tract cancer: The BILCAP randomized study. JN Primrose, R Fox, DH Palmer, R Prasad, D Mirza, DA Anthoney, ... Journal of Clinical Oncology 35 (15_suppl), 4006-4006, 2017 | 218 | 2017 |
| Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade H Toyoda, P Lai, J O'Beirne, CC Chong, S Berhane, H Reeves, D Manas, ... British journal of cancer 114 (7), 744-750, 2016 | 178 | 2016 |
| Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial PN Newsome, R Fox, AL King, D Barton, NN Than, J Moore, C Corbett, ... The Lancet Gastroenterology & Hepatology 3 (1), 25-36, 2018 | 152 | 2018 |
| Biomarker-based prognosis in hepatocellular carcinoma: validation and extension of the BALAD model R Fox, S Berhane, M Teng, T Cox, T Tada, H Toyoda, T Kumada, ... British journal of cancer 110 (8), 2090-2098, 2014 | 64 | 2014 |
| Adjacent Lichen Sclerosis predicts local recurrence and second field tumour in women with vulvar squamous cell carcinoma JKW Yap, R Fox, S Leonard, R Ganesan, ST Kehoe, CW Dawson, ... Gynecologic oncology 142 (3), 420-426, 2016 | 63 | 2016 |
| Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance P Johnson, S Berhane, C Kagebayashi, S Satomura, M Teng, R Fox, ... British journal of cancer 116 (4), 441-447, 2017 | 53 | 2017 |
| National prospective cohort study of the burden of acute small bowel obstruction MJ Lee, AE Sayers, TM Drake, PJ Marriott, ID Anderson, SP Bach, ... BJS open 3 (3), 354-366, 2019 | 49 | 2019 |
| Affordanz/Affordance R Fox, D Panagiotopoulos, C Tsouparopoulou Materiale Textkulturen. Konzepte-Materialien-Praktiken, 2015 | 48 | 2015 |
| Epithelial Na, K-ATPase expression is down-regulated in canine prostate cancer; a possible consequence of metabolic transformation in the process of prostate malignancy A Mobasheri, R Fox, I Evans, F Cullingham, P Martín-Vasallo, CS Foster Cancer cell international 3, 1-10, 2003 | 42 | 2003 |
| Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open … K Arndtz, M Corrigan, A Rowe, A Kirkham, D Barton, RP Fox, L Llewellyn, ... BMJ open 7 (6), e015081, 2017 | 40 | 2017 |
| REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of … A King, D Barton, HA Beard, N Than, J Moore, C Corbett, J Thomas, ... BMJ open 5 (3), e007700, 2015 | 40 | 2015 |
| Greening buildings and communities: costs and benefits G Kats, M James, S Apfelbaum, T Darden, D Farr, R Fox, L Frank, ... Capital E, 2008 | 38 | 2008 |
| Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT1 study JR Marsden, R Fox, NM Boota, M Cook, K Wheatley, LJ Billingham, ... British Journal of Dermatology 176 (5), 1148-1154, 2017 | 36 | 2017 |
| Using prognostic and predictive clinical features to make personalised survival prediction in advanced hepatocellular carcinoma patients undergoing sorafenib treatment S Berhane, R Fox, M García-Fiñana, A Cucchetti, P Johnson British Journal of Cancer 121 (2), 117-124, 2019 | 33 | 2019 |
| Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study S Sebastian, GJ Walker, NA Kennedy, TE Conley, KV Patel, ... The Lancet Gastroenterology & Hepatology 6 (4), 271-281, 2021 | 29 | 2021 |
| Genome-wide analysis of canine oral malignant melanoma metastasis-associated gene expression KL Bowlt Blacklock, Z Birand, LE Selmic, P Nelissen, S Murphy, ... Scientific Reports 9 (1), 6511, 2019 | 25 | 2019 |
| Over-expression of DNMT3A predicts the risk of recurrent vulvar squamous cell carcinomas S Leonard, M Pereira, R Fox, N Gordon, J Yap, S Kehoe, D Luesley, ... Gynecologic oncology 143 (2), 414-420, 2016 | 23 | 2016 |
